At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
MSD corporate responsibility is about the health, social, environmental and economic impact on people and communities around the world.
Our people are our strength, that is why we offer comprehensive total rewards plans that will allow our people to grow personally and professionally. Join our team today.
In the United States and Canada, we are known as Merck & Co., Inc., Rahway, N.J., USA, everywhere else we are known as MSD. Although we have two names globally, we are one company with one purpose. Watch our video to learn more about us. ...
If you have a question or need more information about us, find out who you should contact. Forward-looking statement Cookie policy Cookie 偏好 Privacy Terms of use Accessibility Sitemap Copyright © 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. 本...
1/8,MSD公司(Merck & Co.)$默沙东(MRK)$在FirstWord发布的2024年表现最差制药公司榜单中排名第四,这在一定程度上是因为其HPV疫苗佳达修(Gardasil)在中国的销售疲软,拖累了公司的股价表现。 不过,我们的分析表明,MSD可能有一条积极的前进道路。分析预测,如果佳达修能够获得针对9至26岁男性的适应症批准,可能有助于默...
12/17,在战略性管线调整中,MSD公司(Merck & Co.)$默沙东(MRK)$于周一宣布计划终止后期肿瘤研发项目,涉及抗 TIGIT 抗体 vibostolimab和抗 LAG-3 抗体 favezelimab的开发。这两种疗法均在与 PD-1 抑制剂 Keytruda(帕博利珠单抗)联合使用中进行研究。
MSD globally has been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging human and animal diseases. In the United States and Canada, we are known as Merck & Co., Inc., Rahway, N.J., USA, everywhere else we...
公司在美国与加拿大称为默克(Merck),在其他地区称为默沙东(MSD) 首先对于“默克”这块金子招牌的分配问题,亲兄弟也要选择明算账,经过很多明争暗斗,两家公司重新分配了品牌使用权。如今这两家公司除了共同的名字“默克”之外,已经没有任何联系。应商业需要,双方一致同意,在美国和加拿大,归美国公司(Merck & Co)独家使用...
Connect with us on social media 개인정보처리방침 MSD Privacy 소셜미디어 가이드라인 문의 Sitemap Contact us at 02-331-2000(한국MSD) Accessibility Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. ...